Literature DB >> 3946492

Infective endocarditis in obstetric and gynecologic practice.

B J Seaworth, D T Durack.   

Abstract

Infective endocarditis is an important but uncommon complication in obstetric or gynecologic practice; we found only 124 cases reported in English and selected European papers during the last 40 years. The majority of cases (74%) were caused by streptococci; viridans streptococci predominated, while enterococci and group B streptococci were uncommon except after abortion. The overall mortality rate was 29%, while the mortality rate for the fetus when the mother developed infective endocarditis was 23%. The incidence of endocarditis in this setting is low and seems to be decreasing. Therefore, the risk-benefit ratio may not favor routine use of prophylaxis for endocarditis. We conclude that antibiotics need not be given for prevention of endocarditis before most common obstetric and gynecologic procedures. These include uncomplicated vaginal deliveries, uncomplicated spontaneous or induced abortions, dilatation and curettage, insertion or removal of intrauterine contraceptive devices (in the absence of pelvic infection), and biopsies of the cervix. For patients in whom both the underlying heart lesion and the obstetric or gynecologic procedure seem to pose significant risk for endocarditis, prophylaxis should be given. Two parenteral regimens for patients at highest risk are recommended: ampicillin plus gentamicin or vancomycin plus gentamicin. For lower-risk situations, one oral regimen is suggested: amoxicillin.

Entities:  

Mesh:

Year:  1986        PMID: 3946492     DOI: 10.1016/0002-9378(86)90422-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  Postpartum culture negative endocarditis: a case report and review of the current guidelines.

Authors:  Omar F Ali; Natasha Ratnaraja; Nazim Nathani; Moninder Bhabra; Chetan Varma
Journal:  BMJ Case Rep       Date:  2011-10-04

2.  Family planning requirements of adults with congenital heart disease.

Authors:  L Swan; W S Hillis; A Cameron
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 3.  The risks and benefits of antimicrobial therapy in pregnancy.

Authors:  S M Garland; M A O'Reilly
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

4.  Tricuspid valve endocarditis with Group B Streptococcus after an elective abortion: the need for new data.

Authors:  Erica E Palys; John Li; Paula L Gaut; W David Hardy
Journal:  Infect Dis Obstet Gynecol       Date:  2006

5.  Group B streptococcal endocarditis in obstetric and gynecologic practice.

Authors:  Antonio Crespo; Avi S Retter; Bennett Lorber
Journal:  Infect Dis Obstet Gynecol       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.